Skip to main content

Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells.

Publication ,  Journal Article
Guo, W; Hoque, J; Garcia Garcia, CJ; Spiller, KV; Leinroth, AP; Puviindran, V; Potnis, CK; Gunn, KA; Newman, H; Ishikawa, K; Fujimoto, TN ...
Published in: Sci Transl Med
November 29, 2023

Radiotherapy remains a common treatment modality for cancer despite skeletal complications. However, there are currently no effective treatments for radiation-induced bone loss, and the consequences of radiotherapy on skeletal progenitor cell (SPC) survival and function remain unclear. After radiation, leptin receptor-expressing cells, which include a population of SPCs, become localized to hypoxic regions of the bone and stabilize the transcription factor hypoxia-inducible factor-2α (HIF-2α), thus suggesting a role for HIF-2α in the skeletal response to radiation. Here, we conditionally knocked out HIF-2α in leptin receptor-expressing cells and their descendants in mice. Radiation therapy in littermate control mice reduced bone mass; however, HIF-2α conditional knockout mice maintained bone mass comparable to nonirradiated control animals. HIF-2α negatively regulated the number of SPCs, bone formation, and bone mineralization. To test whether blocking HIF-2α pharmacologically could reduce bone loss during radiation, we administered a selective HIF-2α inhibitor called PT2399 (a structural analog of which was recently FDA-approved) to wild-type mice before radiation exposure. Pharmacological inhibition of HIF-2α was sufficient to prevent radiation-induced bone loss in a single-limb irradiation mouse model. Given that ~90% of patients who receive a HIF-2α inhibitor develop anemia because of off-target effects, we developed a bone-targeting nanocarrier formulation to deliver the HIF-2α inhibitor to mouse bone, to increase on-target efficacy and reduce off-target toxicities. Nanocarrier-loaded PT2399 prevented radiation-induced bone loss in mice while reducing drug accumulation in the kidney. Targeted inhibition of HIF-2α may represent a therapeutic approach for protecting bone during radiation therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Sci Transl Med

DOI

EISSN

1946-6242

Publication Date

November 29, 2023

Volume

15

Issue

724

Start / End Page

eabo5217

Location

United States

Related Subject Headings

  • Stem Cells
  • Receptors, Leptin
  • Mice, Knockout
  • Mice
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Humans
  • Bone Diseases, Metabolic
  • Basic Helix-Loop-Helix Transcription Factors
  • Animals
  • 4003 Biomedical engineering
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guo, W., Hoque, J., Garcia Garcia, C. J., Spiller, K. V., Leinroth, A. P., Puviindran, V., … Wu, C. (2023). Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells. Sci Transl Med, 15(724), eabo5217. https://doi.org/10.1126/scitranslmed.abo5217
Guo, Wendi, Jiaul Hoque, Carolina J. Garcia Garcia, Kassandra V. Spiller, Abigail P. Leinroth, Vijitha Puviindran, Cahil K. Potnis, et al. “Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells.Sci Transl Med 15, no. 724 (November 29, 2023): eabo5217. https://doi.org/10.1126/scitranslmed.abo5217.
Guo W, Hoque J, Garcia Garcia CJ, Spiller KV, Leinroth AP, Puviindran V, et al. Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells. Sci Transl Med. 2023 Nov 29;15(724):eabo5217.
Guo, Wendi, et al. “Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells.Sci Transl Med, vol. 15, no. 724, Nov. 2023, p. eabo5217. Pubmed, doi:10.1126/scitranslmed.abo5217.
Guo W, Hoque J, Garcia Garcia CJ, Spiller KV, Leinroth AP, Puviindran V, Potnis CK, Gunn KA, Newman H, Ishikawa K, Fujimoto TN, Neill DW, Delahoussaye AM, Williams NT, Kirsch DG, Hilton MJ, Varghese S, Taniguchi CM, Wu C. Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells. Sci Transl Med. 2023 Nov 29;15(724):eabo5217.

Published In

Sci Transl Med

DOI

EISSN

1946-6242

Publication Date

November 29, 2023

Volume

15

Issue

724

Start / End Page

eabo5217

Location

United States

Related Subject Headings

  • Stem Cells
  • Receptors, Leptin
  • Mice, Knockout
  • Mice
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Humans
  • Bone Diseases, Metabolic
  • Basic Helix-Loop-Helix Transcription Factors
  • Animals
  • 4003 Biomedical engineering